GanedenBC30 receives GRAS status for use in infant formulas
Ganeden has announced that GanedenBC30 (Bacillus coagulans GBI-30, 6086) has been granted GRAS status for infant formulas from the U.S. Food and Drug Administration (FDA). IFT Daily News
Ganeden has announced that GanedenBC30 (Bacillus coagulans GBI-30, 6086) has been granted GRAS status for infant formulas from the U.S. Food and Drug Administration (FDA). IFT Daily News